HUMACYTE, INC. (HUMA)
Humacytes Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting
Humacytes Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting
Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis
Vontier Earns Top Accolade at International Sustainability Awards
The Radoff-JEC Group Highlights Seer Inc.’s and Chairman and CEO Omid Farokhzad, M.D.’s History of Value Destruction
Hillshire Reserve™ Brand Redefines Lunchmeat for More Versatile, Elevated Everyday Eating
Similarweb Secures Multi-Year, Seven-Figure ARR Contracts Worth Approximately $47 Million in Total Contract Value
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Rectitude Holdings Ltd Secures Additional AIMS System Orders for Major Infrastructure and Residential Projects Across Singapore
JinkoSolar Earns RETCs "Overall Highest Achiever" Award for the Seventh Consecutive Year
Koppers Announces Participation in Upcoming June Investor Conferences